HPV Oncogenes rewire DNA crosslink repair to create a PRIMPOL-dependent therapeutic vulnerability
Cisplatin-based chemoradiation is the standard of care for both HPV-negative (HPV-) and HPV-positive (HPV+) head and neck squamous cell carcinoma (HNSCC),